Gastrointestinal cancer prevention in the United States: The road ahead

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 2, 2003, Pages 81-83

  Metz, David C ^a   Alberts, David S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CARBONATE; EFLORNITHINE; SELENIUM; SULINDAC;

ADENOMATOUS POLYP; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RECURRENCE; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; EDITORIAL; ESOPHAGUS CANCER; HIGH RISK PATIENT; HUMAN; PRECANCER; PRIORITY JOURNAL; SIDE EFFECT; UNITED STATES;

ADENOCARCINOMA; GASTROINTESTINAL NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; UNITED STATES;

EID: 0037320797     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. O'Shaughnessy, J. A., Kelloff, G. J., Gordon, G. B., Dannenberg, A. J., Hong, W. K., Fabian, C, J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S., et al. Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Recommendations of the American Association for Cancer Research Task Force on the treatment and prevention of intraepithelial neoplasia. Clin. Cancer Res., 8: 314-346, 2002.
2. Kelloff, G. J., Sigman, C. C., Johnson, K. M., Boone. C. W., Greenwald, P., Crowell, J. A., Hawk, E. T., and Doody, L. A. Perspectives on surrogate endpoints in the development of drugs that reduce the risk of cancer. Cancer Epidemiol. Biomark. Prev., 9: 127-137, 2000.
3. Lippman, S. M., and Hong. W. K. Cancer prevention by delay. Clin. Cancer Res., 8: 305-313, 2002.
4. Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N. Engl. J. Med., 329: 1977-1981, 1993.
5. O, Brien, M. J., Winawer. S. J., Zauber, A. G., Gottlieb, L. S., Sternberg, S. S., Diaz, B., Dickersin, G. R., Ewing, S., Geller. S., Kasimian, D., et al. The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology, 98: 371-379, 1990.
6. Rex, D. K., Cutler, C. S., Lemmel, G. T., Rahmani. E. Y., Clark, D. W., Helper, D. J., Lehman, G. A., and Mark, D. G. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology, 112: 24-28, 1997.
7. Cancer facts and figures 2001, Publication No. 5008.01. Atlanta: American Cancer Society, 2001.
8. Blot, W. J., and McGlaughlin, J. K. The changing epidemiology of esophageal cancer. Semin. Oncol., 26: 2-8, 1999.
9. Lagergren, J., Bergstrom, R., Lindgren, A., and Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med., 340: 825-831, 1999.
10. Cameron, A. J., Lomboy, C. T., Pera, M., and Carpenter, H. A. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology, 109: 1541-1546, 1995.
11. DeVault, K. R., and Castell, D. O., and the Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. J. Gastroenterol., 94: 1434-1442, 1999.
12. Provenzale, D., Schmitt, C., and Wong, J. B. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am. J. Gastroenterol., 94: 2043-2053, 1999.
13. Spechler, S. J. Barrett's esophagus. N. Engl. J. Med., 346: 836-842, 2002.
14. Rustgi, A. K. Biomarkers for malignancy in the columnar-lined esophagus. Gastroenterol. Clin. N. Am., 26: 599-606, 1997.
15. Baron, J. A., Cole, B. F., Mott, L. A., and For the Polyp Prevention Study Group. Aspirin chemoprevention of colorectal adenomas. Proc. Am. Assoc Cancer Res., 43: 669, 2002.
16. Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N. Engl. J. Med., 340: 101-107, 1999.
17. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, W., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B. The effect of Celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342: 1946-1962, 2000.
18. Meyskens, F. L., and Gerner, E. W. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin. Cancer Res., 5: 945-951, 1999.
19. Giardello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with Sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
20. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc., 276: 1957-1963, 1996.
21. Silverstein, F. E., Faich, G., Goldstein. J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., Burr, A. M., et al. Gastrointestinal toxicity with celecoxib versus nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. J. Am. Med. Assoc., 284: 1247-1255, 2000.
22. Janne, P. A., and Mayer, R. J. Chemoprevention of colorectal cancer, N. Engl. J. Med., 342: 1960-1968, 2000.